These in vitro and in vivo models of conditional SAE2 knockdown may further facilitate the discovery of novel SUMO pathway biomarkers and enable additional studies to more precisely determine the exact SUMO dependent cellular pathways that promote cancer cell growth and tumor maintenance. Here, UBA2 is linked to cancer.